Respiratory Health — Strong Clinical Trial Support
Real, controlled human trials back this one convincingly. A 2026 consensus review of multiple RCTs found that NAC significantly reduced inflammatory markers (IL-8, CRP) and improved lung function markers, cough and mucus symptoms, with higher doses (1,200mg) outperforming lower doses and placebo — and CRP fully normalising in 90% of patients on the higher dose [35]. This kind of dose-responsive, statistically clean result across multiple trials is exactly the sort of evidence that's rare in the natural supplement space.
Mental & Cognitive Health — A Genuinely Exciting, Expanding Field
NAC has moved well beyond its original mucolytic use into psychiatry, and the results are compelling. A review of the evidence found oral NAC (2,000–2,400mg/day) is well tolerated and supported as an adjunctive therapy across a range of psychiatric conditions, working through its effects on glutamate, oxidative stress and inflammation in the brain [55]. Broader condition-by-condition evidence supports potential benefit in areas including compulsive and addictive behaviours, mood regulation, and cognitive support [39][48]. A systematic review of neurological conditions found NAC's strongest signals in acute mild traumatic brain injury (meaningful improvement in symptom resolution) and Parkinson's disease (improved dopamine transporter binding with combined IV/oral use), with encouraging early trends in Alzheimer's [37]. This field is moving fast and NAC's excellent safety profile means it's being tested widely — one of the more promising natural compounds in brain health research today.
Exercise Performance & Antioxidant Capacity
A systematic review of 16 controlled trials in healthy active adults found NAC supplementation reliably improved antioxidant capacity and glutathione levels, with most trials also reporting genuine exercise performance benefits — all without a single serious adverse event across the trials reviewed [38].